| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/ANE.12481 |
| P698 | PubMed publication ID | 26358197 |
| P50 | author | Katja Werlenius | Q86108003 |
| P2093 | author name string | B Rydenhag | |
| B Fekete | |||
| C Örndal | |||
| P2860 | cites work | Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1 | Q24651548 |
| Treatment outcome and prognostic factors of adult glioblastoma multiforme | Q26824439 | ||
| MGMT gene silencing and benefit from temozolomide in glioblastoma | Q27824832 | ||
| Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma | Q27860910 | ||
| Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma | Q30560444 | ||
| Presenting symptoms of glioma in adults. | Q30855623 | ||
| Epidemiology and etiology of gliomas | Q30981828 | ||
| A comparison of long-term survivors and short-term survivors with glioblastoma, subventricular zone involvement: a predictive factor for survival? | Q33573296 | ||
| A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival | Q34108339 | ||
| Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma | Q34584754 | ||
| Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response | Q35779256 | ||
| A population-based study on the effect of temozolomide in the treatment of glioblastoma multiforme | Q36179190 | ||
| Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. | Q36673354 | ||
| Glioma extent of resection and its impact on patient outcome | Q37170201 | ||
| Evaluation of outcome and prognostic factors in patients of glioblastoma multiforme: A single institution experience | Q37254651 | ||
| Survival of patients with glioblastoma multiforme has not improved between 1993 and 2004: analysis of 625 cases. | Q40174718 | ||
| Gross total but not incomplete resection of glioblastoma prolongs survival in the era of radiochemotherapy | Q42623558 | ||
| Patterns of care and survival in a retrospective analysis of 1059 patients with glioblastoma multiforme treated between 2002 and 2007: a multicenter study by the Central Nervous System Study Group of Airo (italian Association of Radiation Oncology). | Q42965233 | ||
| A proposed classification system that projects outcomes based on preoperative variables for adult patients with glioblastoma multiforme | Q43264530 | ||
| Multivariate analysis of prognostic factors in patients with glioblastoma | Q43493829 | ||
| A survival analysis of GBM patients in the West of Scotland pre- and post-introduction of the Stupp regime | Q44141105 | ||
| Survival rates in patients with low-grade glioma after intraoperative magnetic resonance image guidance | Q44856308 | ||
| Glioblastoma: clinical characteristics, prognostic factors and survival in 492 patients | Q45753988 | ||
| Delay in radiotherapy shortens survival in patients with high grade glioma | Q48131487 | ||
| Overall survival, prognostic factors, and repeated surgery in a consecutive series of 516 patients with glioblastoma multiforme | Q48268487 | ||
| Prognosis factors of survival time in patients with glioblastoma multiforme: a multivariate analysis of 340 patients | Q48288083 | ||
| Surgical management of newly diagnosed glioblastoma in adults: role of cytoreductive surgery | Q48961397 | ||
| Survival in high-grade glioma: a study of survival in patients unfit for or declining radiotherapy. | Q52857893 | ||
| Clinical trial participation and outcome for patients with glioblastoma: multivariate analysis from a comprehensive dataset. | Q55461673 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | glioblastoma | Q282142 |
| P304 | page(s) | 434-441 | |
| P577 | publication date | 2015-09-11 | |
| P1433 | published in | Acta Neurologica Scandinavica | Q4676732 |
| P1476 | title | Prognostic factors for glioblastoma patients--a clinical population-based study | |
| P478 | volume | 133 |
| Q47809269 | Determinants for Effective ALECSAT Immunotherapy Treatment on Autologous Patient-Derived Glioblastoma Stem Cells |
| Q39243880 | Family caregivers' level of mastery predicts survival of patients with glioblastoma: A preliminary report |
| Q39222102 | Incidence of neuroepithelial primary brain tumors among adult population of Emilia-Romagna Region, Italy |
| Q47706983 | Influence of neutrophil-lymphocyte ratio in prognosis of glioblastoma multiforme |
| Q48299999 | Molecular profiling of short-term and long-term surviving patients identifies CD34 mRNA level as prognostic for glioblastoma survival. |
| Q89695820 | Patterns of care and clinical outcome in assumed glioblastoma without tissue diagnosis: A population-based study of 131 consecutive patients |
| Q92741369 | Postoperative oscillatory brain activity as an add-on prognostic marker in diffuse glioma |
| Q37641600 | Predicting the cell death responsiveness and sensitization of glioma cells to TRAIL and temozolomide |
| Q48116084 | Prognostic parameters and outcome after re-irradiation for progressive glioblastoma. |
| Q38926867 | Secondary Glioblastoma: Molecular and Clinical Factors That Affect Outcome After Malignant Progression of a Lower Grade Tumor. |
Search more.